In short
Most people recover from Bell's palsy, but a third of moderate and severe cases leave lasting problems. The 2022 guideline covers staging, electrodiagnostic testing that predicts outcome, and combined treatment.
What this guide covers: Why the nerve fails · Presentation · Staging and assessment · Electrodiagnostic testing · Differential diagnosis
Bell's palsy — idiopathic facial nerve paralysis — is the commonest cause of facial nerve weakness, accounting for 60 to 75 percent of cases, with an incidence of roughly 11 to 53 per 100,000. It produces sudden weakness of the muscles on one side of the face and, because it affects expression, it has an outsized impact on how patients see themselves and how they are seen.
The Chinese 2022 clinical guideline on neurorestorative treatment of idiopathic facial palsy sets out how the condition is staged, how prognosis is assessed, and what combination of treatments is recommended.
Why the nerve fails
In severe cases the nerve swells within its sheath, raising intraneural pressure and compromising blood flow, which increases the oedema further — a vicious cycle that can lead to axonal necrosis and demyelination. Later, misdirected regeneration produces the synkinesis that patients find most troublesome: the eye closing when they smile, or the mouth twitching when they blink.
Presentation
Onset is typically in people aged 20 to 40, slightly more often in men, and almost always unilateral. It is abrupt: the corner of the mouth droops, speech leaks air, and the patient cannot raise the eyebrow, close the eye, show the teeth or puff out the cheek. Food collects in the cheek and saliva dribbles. Tears spill because the lower lid is everted. Some patients have retroauricular pain for a few days beforehand, and weakness usually peaks within 72 hours.
Examination shows a flattened nasolabial fold, a widened palpebral fissure and loss of forehead wrinkling on the affected side. On attempted eye closure the eye rolls upward — Bell's phenomenon.
The site of the lesion changes the picture. Proximal to the geniculate ganglion there is loss of taste over the anterior two-thirds of the tongue and hyperacusis. At the geniculate ganglion, herpes zoster infection produces Ramsay Hunt syndrome with vesicles in the external canal and reduced sensation. Near the stylomastoid foramen there is facial weakness plus retroauricular tenderness.
Staging and assessment
Acute phase is the first fifteen days; recovery phase from sixteen days to six months; sequelae phase beyond six months.
Grading uses House-Brackmann, the Burres-Fisch score, and the Sunnybrook system; the Facial Disability Index captures the quality-of-life impact.
Electrodiagnostic testing
This is where prognosis is decided. The nerve excitability test compares the threshold current needed to produce muscle contraction on each side; a difference of 2 to 3.5 mA indicates degeneration. Within the first ten days, a normal excitability test predicts complete recovery in about 88 percent of patients, reduced response in about 73 percent, and absent response means recovery will not occur.
Electroneurography compares the compound muscle action potential amplitude with the healthy side and is the best quantitative measure of axonal loss. Degeneration below 90 percent at three weeks supports continued conservative treatment; reaching 90 percent by day six, or a rapid increase of 15 to 20 percent over two days, is an indication to consider surgical exploration.
Needle electromyography is best performed at two to three weeks, when wallerian degeneration is complete; earlier testing under-detects axonal loss. Fibrillation potentials and reduced recruitment denote severe injury, while a recordable evoked potential with normal latency indicates neurapraxia and a good prognosis.
Differential diagnosis
Central facial weakness spares the forehead, and this distinction comes first. Among peripheral causes, about 75 percent are Bell's palsy and the rest require investigation: Guillain-Barre syndrome with bilateral weakness and albuminocytological dissociation, Lyme disease with erythema migrans, diabetic mononeuropathy, secondary palsy from parotitis, otitis media or skull base tumours, and traumatic palsy after basal skull fracture.
Treatment
The guideline endorses combined treatment. Corticosteroids started early shorten the inflammatory phase; antiviral agents are added where herpes zoster is suspected; B vitamins, dehydrating agents where oedema is significant, physical therapy and facial muscle training are used alongside. Acupuncture and neurorestorative techniques are part of the combined approach described.
Sequelae
Incomplete recovery leaves muscle atrophy, hemifacial spasm, synkinesis and a sense of tightness. The commonest synkinesis patterns are upper lip twitching on blinking, involuntary eye closure on smiling, forehead contraction on attempted eye closure, and crocodile tears with flushing and sweating while eating.
Practical advice
Early assessment within the first ten days matters because that is when electrodiagnosis is most informative. Protect the eye with lubrication and taping if closure is incomplete — corneal exposure is the complication that causes permanent damage. And be aware that recovery is measured in months, not days.
Sources and further reading
One reference to a U.S. government health source (National Institutes of Health or MedlinePlus) for the medical background of this guide. It is context, not a substitute for advice from your treating doctor.
General information for international patients, not medical advice or a diagnosis. Read the medical disclaimer.





